OCLAReport2022.md 669 B

Denis Rancourt's VAERS study

AE = (Major) Adverse event

Examines VAERS data by: Major Adverse Effect, Manufacturer, Type/Date of injection, Onset/Finality of AE, Age

Summary

  • "At-risk" group suffer worst AE
  • Large peak in first 5 days
  • Exponential decrease of AE ~ 30 days
  • Plateau of AE ~60+ days with COVID symptoms
  • High occurrence for 2nd dose

Notes

  • Exponential decay indicates casual link (background deaths have uniform distribution)
  • Decay cosnistent with prevalence of S protein
  • Propose enhanced immune response in 2nd dose which both increases AE and decreases antigen production, reducing efficacy
  • JJ : MDRNA : Pfizer => 4 : 1.3 : 1